Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Studyfor Prostate Carcinoma8 locations incl. DuarteSponsor: University of WashingtonSex: Male·Age: 40+·Accepts healthy volunteersCode: NCT04472338·RecruitingApply to this trial
Identifying and Caring for Individuals With Inherited Cancer Syndromefor BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome2 locations incl. PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 18+·Accepts healthy volunteersCode: NCT04494945·RecruitingApply to this trial
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disordersfor BCR-JAK2 Fusion Protein ExpressionDrug: Ruxolitinib4 locations incl. Palo AltoSponsor: William ShomaliSex: All·Age: 18+Code: NCT03801434·Phase 2·RecruitingApply to this trial
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemiafor Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeDrug: Ruxolitinib3 locations incl. ColumbusSponsor: Jennifer SaultzSex: All·Age: 18+Code: NCT03874052·Phase 1·RecruitingApply to this trial
Targeted Pathway Inhibition in Patients With Pancreatic Cancerfor Locally Advanced Pancreatic Ductal Adenocarcinoma1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 18+Code: NCT04005690·EARLY_Phase 1·RecruitingApply to this trial
Feasibility of FMISO in Brain Tumorsfor Malignant Brain Neoplasm1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 18+Code: NCT03649880·Phase 2·RecruitingApply to this trial
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous Systemfor Central Nervous System Neoplasm1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 10+Code: NCT03270059·Phase 2·RecruitingApply to this trial
Quantitative MRI Assessment of Breast Cancer Therapy Responsefor Breast Cancer4 locations incl. Iowa CitySponsor: Corewell Health EastSex: All·Age: 18+Code: NCT05704062·RecruitingApply to this trial
Pathogenesis of Hematologic Malignanciesfor Acute Leukemia1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 1+Code: NCT01728402·Enrolling By Invitation